Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

185.96 +3.24 (+1.77%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

24 25 Next >

Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 28, 2022

Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.

Via Benzinga

Swvl Layoffs 2022: What to Know About the Latest SWVL Job Cuts ↗

November 28, 2022

Swvl (SWVL) layoffs are here again as the micro-mobility company seeks to reduce costs by cutting more than 50% of its workforce.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

November 28, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $13,000 Today ↗

November 28, 2022

Via Benzinga

Is Axsome Therapeutics Stock a Buy Now? ↗

November 11, 2022

The company seems to be coming into its own.

Via The Motley Fool

Why Axsome Therapeutics Stock Is Bolting Higher Today ↗

November 08, 2022

The biotech's promising Q3 earnings report has investors excited about the future.

Via The Motley Fool

Why Is Axsome Therapeutics (AXSM) Stock Up 32% Today? ↗

November 28, 2022

Axsome Therapeutics (AXSM) stock is soaring higher on Monday after releasing positive results from a Phase 3 clinical trial.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 28, 2022

Via Benzinga

Stocks Stumbling After Thanksgiving Week ↗

November 28, 2022

The Dow Jones Industrial Average is extending its premarket losses, down 265 points at midday, as protests in China over the country's zero-Covid policy weigh on investor sentiment globally.

Via Talk Markets

Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher ↗

November 28, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Monday.

Via Benzinga

US Stocks Start Week On Lower Note, Dow Drops Over 100 Points ↗

November 28, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Monday.

Via Benzinga

Axsome Therapeutics (AXSM) Q3 2022 Earnings Call Transcript ↗

November 07, 2022

AXSM earnings call for the period ending September 30, 2022.

Via The Motley Fool

Recap: Axsome Therapeutics Q3 Earnings ↗

November 07, 2022

Axsome Therapeutics (NASDAQ:AXSM) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Axsome Therapeutics Unusual Options Activity ↗

November 28, 2022

Someone with a lot of money to spend has taken a bullish stance on Axsome Therapeutics (NASDAQ:AXSM). And retail traders should know. We noticed this today when the big position showed up on publicly...

Via Benzinga

Analyst Says Coinbase 'A Waste Of Time', Taylor Swift's Concert Fiasco Under DOJ Probe, Shopify Clocks Record Black Friday Sales: Top Stories Monday, Nov. 28 ↗

November 28, 2022

CNBC

Via Benzinga

Biogen Dives On Reports Of Alzheimer's Death While Axsome Soars On Its Study Success ↗

November 28, 2022

Biogen and Axsome stocks diverged Monday on news out of their Alzheimer's studies.

Via Investor's Business Daily

Why Axsome Therapeutics Stock Is Soaring Today ↗

November 28, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday morning after the company announced AXS-05 achieved its primary endpoint in the ACCORD Phase 3 trial in Alzheimer's disease...

Via Benzinga

Axsome Therapeutics Investigational Drug Lowers Risk Of Agitation Relapse In Alzheimer's Patients ↗

November 28, 2022

Axsome Therapeutics Inc's (NASDAQ: AXSM) AXS-05 substantially and statistically significantly delayed the time to relapse and prevented relapse of agitation in patients with Alzheimer's disease,...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 28, 2022

Via Benzinga

Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer’s Disease Agitation

November 28, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Want to Double Your Money? Buying These Stocks Could be a Genius Move ↗

November 28, 2022

These stocks are undervalued considering their long-term growth potential.

Via The Motley Fool

3 Growth Stocks to Buy That Could Skyrocket ↗

November 28, 2022

The future looks promising for all three of these stocks.

Via The Motley Fool

Prediction: This Growth Stock Could Double in 2023 ↗

November 24, 2022

The next year should be a busy one for this drugmaker.

Via The Motley Fool

Axsome Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference

November 23, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Got $500? 3 Growth Stocks to Buy That Could Double Your Money ↗

November 20, 2022

Innovative products and services could keep these companies growing.

Via The Motley Fool

These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher. ↗

November 18, 2022

The good times could keep on rolling for these big winners.

Via The Motley Fool

Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology Conference

November 09, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday ↗

November 09, 2022

U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Axsome Therapeutics Stock Slipped Today ↗

November 07, 2022

Investors traded out of the company following the latest earnings release, but only to a modest degree.

Via The Motley Fool

Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

November 07, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.